Mimedx (MDXG) Tax Provisions (2013 - 2026)
Mimedx's (MDXG) quarterly Tax Provisions came in at -$4.5 million in Q1 2026, down 381.37% year-on-year from $1.6 million in Q1 2025, and down 167.7% quarter-over-quarter from $6.6 million in Q4 2025.
Mimedx (MDXG) Tax Provisions (2013 - 2026) Analysis & Trends
Mimedx has disclosed Tax Provisions across 14 years of filings, most recently posting -$4.5 million for Q1 2026.
- Tax Provisions for Q1 2026 came in at -$4.5 million, down 381.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (down 20.04% YoY), and the FY2025 annual result was $17.7 million, up 15.61% from the prior year.
- Tax Provisions came in at -$4.5 million for Q1 2026 at Mimedx, down from $6.6 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $6.6 million in Q4 2025 to a low of -$37.4 million in Q4 2023.
- The 5-year median for Tax Provisions is $591000.0 (2023), against an average of -$476117.6.
- Across the five-year window, Tax Provisions sank 133582.14% in 2023 and jumped 7660.81% in 2024, its largest moves.
- Mimedx's Tax Provisions stood at $28000.0 in 2022, then tumbled by 133582.14% to -$37.4 million in 2023, then soared by 110.2% to $3.8 million in 2024, then soared by 73.29% to $6.6 million in 2025, then plunged by 167.7% to -$4.5 million in 2026.
- The last three Tax Provisions figures came in at -$4.5 million (Q1 2026), $6.6 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | -4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.47 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | -37.38 Mn |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | -108,000.00 |
| Sep 30, 2021 | 301,000.00 |
| Jun 30, 2021 | -5,000.00 |